MILLENNIUM MANAGEMENT LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$709,099
-72.4%
1,190,563
-73.4%
0.00%
-100.0%
Q2 2023$2,571,615
+6428937.5%
4,470,818
+7848.5%
0.00%
Q1 2023$40
-97.1%
56,247
-90.8%
0.00%
-100.0%
Q4 2022$1,385
-99.7%
612,909
+286.9%
0.00%
Q3 2022$507,000
-96.4%
158,411
-94.0%
0.00%
-100.0%
Q1 2022$14,263,000
-38.0%
2,646,223
+55.4%
0.01%
-41.7%
Q4 2021$23,000,000
+94.9%
1,702,403
+159.1%
0.01%
+71.4%
Q3 2021$11,799,000
+19.3%
656,953
+14.0%
0.01%
+16.7%
Q2 2021$9,891,000
+358.3%
576,389
+434.2%
0.01%
+200.0%
Q1 2021$2,158,000
-82.4%
107,903
-85.0%
0.00%
-77.8%
Q4 2020$12,254,000
+561.3%
720,838
+545.5%
0.01%
+350.0%
Q3 2020$1,853,000
-14.4%
111,673
+19.4%
0.00%
-33.3%
Q2 2020$2,165,000
-9.5%
93,492
-30.2%
0.00%
-40.0%
Q1 2020$2,391,000
-83.0%
133,975
-79.5%
0.01%
-72.2%
Q4 2019$14,082,000
-21.9%
652,420
-34.1%
0.02%
-37.9%
Q3 2019$18,034,000
-68.0%
990,098
+7.2%
0.03%
-58.0%
Q3 2018$56,278,000
-24.1%
923,202
-39.2%
0.07%
-28.9%
Q2 2018$74,153,000
-38.1%
1,518,593
+34.8%
0.10%
-39.4%
Q1 2018$119,737,000
+5974.9%
1,126,828
+3314.6%
0.16%
+5233.3%
Q4 2017$1,971,000
-81.7%
33,000
-92.8%
0.00%
-85.0%
Q1 2017$10,783,000
+110.6%
459,457
+10.1%
0.02%
+81.8%
Q4 2016$5,120,000
-32.2%
417,312
-5.0%
0.01%
-15.4%
Q3 2016$7,551,000
+1020.3%
439,503
+828.0%
0.01%
+550.0%
Q2 2016$674,000
-97.3%
47,359
-97.4%
0.00%
-96.8%
Q1 2016$25,342,000
+36.7%
1,843,044
+67.6%
0.06%
+61.5%
Q4 2015$18,533,000
-58.1%
1,099,867
-72.7%
0.04%
-54.7%
Q3 2015$44,224,000
+794.7%
4,035,015
+921.3%
0.09%
+855.6%
Q2 2015$4,943,000
-47.0%
395,100
-53.4%
0.01%
-47.1%
Q1 2015$9,333,000
-15.9%
848,485
+18.4%
0.02%
-29.2%
Q4 2014$11,104,000
+226.8%
716,356
+154.5%
0.02%
+166.7%
Q3 2014$3,398,000
-35.4%
281,511
-31.4%
0.01%
-40.0%
Q2 2014$5,259,000
+169.3%
410,186
+154.5%
0.02%
+150.0%
Q1 2014$1,953,000
-2.5%
161,168
-8.7%
0.01%0.0%
Q4 2013$2,004,000
-84.7%
176,583
-85.9%
0.01%
-85.7%
Q3 2013$13,087,000
+21.6%
1,252,872
+34.4%
0.04%
+27.3%
Q2 2013$10,763,000931,8510.03%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders